Open Access System for Information Sharing

Login Library

 

Article
Cited 15 time in webofscience Cited 16 time in scopus
Metadata Downloads

Protective effects of basic fibroblast growth factor in the development of emphysema induced by interferon-gamma

Title
Protective effects of basic fibroblast growth factor in the development of emphysema induced by interferon-gamma
Authors
Lee, BJMoon, HGShin, TSJeon, SGLee, EYGho, YSLee, CGZhu, ZElias, JAKim, YK
POSTECH Authors
Gho, YSKim, YK
Date Issued
Apr-2011
Publisher
KOREAN SOC MED BIOCHEMISTRY MOLECULAR BIOLOGY
Abstract
Recent clinical evidence indicates that the non-eosinophilic subtype of severe asthma is characterized by fixed airway obstruction, which may be related to emphysema. Transgenic studies have demonstrated that high levels of IFN-gamma in the airways induce emphysema. Fibroblast growth factor 2 (FGF2), which is the downstream mediator of TGF-beta, is important in wound healing. We investigated the role of FGF2 in IFN-gamma-induced emphysema and the therapeutic effects of recombinant FGF2 in the prevention of emphysema in a severe non-eosinophilic asthma model. To evaluate the role of FGF2 in IFN-gamma-induced emphysema, lung targeted IFN-gamma transgenic mice were cross-bred with FGF2-deficient mice. A severe non-eosinophilic asthma model was generated by airway application of LPS-containing allergens twice a week for 4 weeks. To evaluate protective effects of FGF2, recombinant FGF2 (10 mu g) was injected subcutaneously during allergen challenge in the severe asthma model. We found that non-eosinophilic inflammation and emphysema induced by transgenic overexpression of IFN-gamma in the airways were aggravated by the absence of FGF2. Airway challenge with LPS-containing allergens induced more inflammation in mice sensitized with LPS-containing allergens compared to challenge with allergens alone. In addition, LPS-induced lung inflammation and emphysema depended on IFN-gamma, but not on IL-13. Interestingly, emphysema in the severe asthma model was significantly inhibited by treatment with recombinant FGF2 during allergen challenge, whereas lung inflammation was unaffected. Therefore, our present data suggest that FGF2 may help protect against IFN-gamma-induced emphysema, and that recombinant FGF2 may help lessen the severity of emphysema.
URI
http://oasis.postech.ac.kr/handle/2014.oak/17421
DOI
10.3858/EMM.2011.43.4.018
ISSN
1226-3613
Article Type
Article
Citation
EXPERIMENTAL AND MOLECULAR MEDICINE, vol. 43, no. 4, page. 169 - 178, 2011-04
Files in This Item:

qr_code

  • mendeley

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher

 GHO, YONG SONG
Dept of Life Sciences
Read more

Views & Downloads

Browse